


Searching News Database: H3 Biomedicine
HSMN NewsFeed - 17 Aug 2021
Remix Therapeutics Names Peter Smith, PhD, as President and Chief Executive Officer
Remix Therapeutics Names Peter Smith, PhD, as President and Chief Executive Officer
HSMN NewsFeed - 1 Apr 2015
ImmunoGen, Inc. Appoints Anna Berkenblit, MD, MMSc Vice President and Chief Medical Officer
ImmunoGen, Inc. Appoints Anna Berkenblit, MD, MMSc Vice President and Chief Medical Officer
HSMN NewsFeed - 27 Jan 2011
H3 Biomedicine Launches to Discover and Develop Next Generation Cancer Treatments
H3 Biomedicine Launches to Discover and Develop Next Generation Cancer Treatments
